Artis Ventures Management, L.P.
SEC exempt reporting adviser (venture capital exemption).
- Website
- https://www.av.co
- HQ
- CA
Artis Ventures invests in frontier technologies with the aim of making the future of the human condition more resilient. The firm's team includes Founder and Managing Partner Stuart Peterson, Senior Partners Austin Walne and Ruchita Sinha, Partners Henry Klingenstein and Omair Khan, Operating Partner Michael Yang, and Investor Alex Real, MD-PhD.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| ARTIS Select II, L.P. Invests in frontier technologies to make the future of the human condition more resilient, supporting visionary founders reimagining systems that sustain life, with a focus on health, AI, and longevity. Inferred from the firm's website | approx. 2026 | $50M (Form D) | Raising |
| Artis TechBio Select I, L.P. Invests in frontier technologies to make the future of the human condition more resilient, supporting visionary founders reimagining systems that sustain life, with a focus on health, AI, and longevity. Inferred from the firm's website | 2024 | $21.71M (Form D) | Open, writing first checks |
| Artis TechBio II (Offshore), L.P. Invests in frontier technologies to make the future of the human condition more resilient, supporting visionary founders reimagining systems that sustain life, with a focus on health, AI, and longevity. Inferred from the firm's website | 2022 | $62.88M (Form D) | Late investment period |
| Artis TechBio II, L.P. Invests in frontier technologies to make the future of the human condition more resilient, supporting visionary founders reimagining systems that sustain life, with a focus on health, AI, and longevity. Inferred from the firm's website | 2022 | $140.81M to $300M (Form D) | Late investment period |
03 · People across funds
- Robert Riemer, Executive Officer of Artis Ventures Management IV, LLC, the General Partner
ARTIS Select II, L.P. (Named on Form D); Artis TechBio Select I, L.P. (Named on Form D); Artis TechBio II (Offshore), L.P. (Named on Form D); Artis TechBio II, L.P. (Named on Form D)
- Stuart Peterson, Managing Partner
ARTIS Select II, L.P. (Named on Form D); Artis TechBio Select I, L.P. (Named on Form D); Artis TechBio II (Offshore), L.P. (Named on Form D); Artis TechBio II, L.P. (Named on Form D)
- Alex Real, MD-PhD, Investor
ARTIS Select II, L.P. (Team); Artis TechBio Select I, L.P. (Team); Artis TechBio II (Offshore), L.P. (Team); Artis TechBio II, L.P. (Team)
- Austin Walne, Senior Partner
ARTIS Select II, L.P. (Team); Artis TechBio Select I, L.P. (Team); Artis TechBio II (Offshore), L.P. (Team); Artis TechBio II, L.P. (Team)
- Henry Klingenstein, Partner
ARTIS Select II, L.P. (Team); Artis TechBio Select I, L.P. (Team); Artis TechBio II (Offshore), L.P. (Team); Artis TechBio II, L.P. (Team)
- Michael Yang, Operating Partner
ARTIS Select II, L.P. (Team); Artis TechBio Select I, L.P. (Team); Artis TechBio II (Offshore), L.P. (Team); Artis TechBio II, L.P. (Team)
- Omair Khan, Partner
ARTIS Select II, L.P. (Team); Artis TechBio Select I, L.P. (Team); Artis TechBio II (Offshore), L.P. (Team); Artis TechBio II, L.P. (Team)
- Ruchita Sinha, Senior Partner
ARTIS Select II, L.P. (Team); Artis TechBio Select I, L.P. (Team); Artis TechBio II (Offshore), L.P. (Team); Artis TechBio II, L.P. (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026